标题
miRNAs mediated drug resistance in hematological malignancies
作者
关键词
Cancer drug resistance, Hematological malignancies, microRNAs, Drug sensitivity
出版物
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-21
DOI
10.1016/j.semcancer.2021.03.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities
- (2020) Kanisha Shah et al. CURRENT DRUG METABOLISM
- Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival
- (2020) Ramkrishna Mitra et al. Nature Communications
- RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
- (2020) Gurvinder Kaur et al. Blood Cancer Journal
- Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
- (2020) Felice Pepe et al. Journal of Clinical Medicine
- Deep Sequencing Analysis Reveals Distinctive Non-Coding RNAs When Comparing Tumor Multidrug-Resistant Cells and Extracellular Vesicles with Drug-Sensitive Counterparts
- (2020) Diana Sousa et al. Cancers
- Multiple Myeloma: Available Therapies and Causes of Drug Resistance
- (2020) Vanessa Pinto et al. Cancers
- Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma
- (2020) Stefania Raimondo et al. Cancers
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- Expression of non-coding RNAs in hematological malignancies
- (2020) Soudeh Ghafouri-Fard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
- (2020) Vanessa Desantis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy
- (2020) Yu-Ling Li et al. Human Cell
- The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
- (2020) Cristina P. R. Xavier et al. Cells
- Sorting Mechanisms for MicroRNAs into Extracellular Vesicles and Their Associated Diseases
- (2020) Michael Groot et al. Cells
- MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma
- (2020) Lun Zhang et al. CANCER LETTERS
- The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity?
- (2020) Orazio Fortunato et al. Pharmaceuticals
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
- (2019) Jian Xu et al. MOLECULAR THERAPY
- MicroRNA‐26a inhibits multiple myeloma cell growth by suppressing cyclin‐dependent kinase 6 expression
- (2019) Ying‐Ying Xu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
- (2019) Maria Cucè et al. Journal of Hematology & Oncology
- Development of micro RNA ‐based therapeutic approaches for cancer patients
- (2019) Ryou‐u Takahashi et al. CANCER SCIENCE
- Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
- (2019) Yan Liu et al. Journal of Hematology & Oncology
- Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kB-dependent P-glycoprotein upregulation
- (2019) Su-Fern Tan et al. JOURNAL OF LIPID RESEARCH
- miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1
- (2019) Xiaoli Yuan et al. CELL CYCLE
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
- (2019) Lim et al. Cancers
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4
- (2019) Yaxun Wu et al. PATHOLOGY RESEARCH AND PRACTICE
- Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
- (2019) Marjan Yaghmaie et al. Current Hematologic Malignancy Reports
- Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes
- (2019) Morayma M Temoche-Diaz et al. eLife
- Autophagy: A novel mechanism of chemoresistance in cancers
- (2019) Xinyu Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
- (2019) Jahangir Abdi et al. BMC CANCER
- miR-155 as a novel clinical target for hematological malignancies
- (2019) Lisa Witten et al. CARCINOGENESIS
- Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
- (2019) Marcelo A. Mori et al. Cell Metabolism
- Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
- (2019) M. Helena Vasconcelos et al. DRUG RESISTANCE UPDATES
- Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis
- (2019) Hironori Matsuyama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- microRNA-375 regulates glucose metabolism-related signaling for insulin secretion
- (2019) Olivier Dumortier et al. JOURNAL OF ENDOCRINOLOGY
- MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target
- (2018) Suwei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin
- (2018) Ni Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2
- (2018) Yingjun Deng et al. BIOSCIENCE REPORTS
- Metazoan MicroRNAs
- (2018) David P. Bartel CELL
- microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells
- (2018) Peng-Hsu Chen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effect of ABCG2 , OCT1 , and ABCB1 ( MDR1 ) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial
- (2018) Sébastien Rinaldetti et al. Clinical Lymphoma Myeloma & Leukemia
- Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365
- (2018) Qing-Hua Min et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia
- (2018) Elaheh S. Ghodousi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1
- (2018) Lin Wan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
- (2018) Nasrin Rastgoo et al. LEUKEMIA
- KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast cancer
- (2018) Wenyu Wang et al. MOLECULAR CANCER THERAPEUTICS
- Derepression of co-silenced tumor suppressor genes by nanoparticle-loaded circular ssDNA reduces tumor malignancy
- (2018) Jing Meng et al. Science Translational Medicine
- MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3
- (2018) Kyung Hee Koo et al. Cell Death & Disease
- The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer
- (2018) Chiranjib Chakraborty et al. Oncotarget
- Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
- (2018) Hao Wang et al. Clinical Epigenetics
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
- (2018) Anita G. Seto et al. BRITISH JOURNAL OF HAEMATOLOGY
- miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2
- (2018) Bin Pan et al. EXPERIMENTAL HEMATOLOGY
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
- (2018) Klara Srutova et al. HAEMATOLOGICA
- Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance
- (2018) Yuhua Feng et al. Epigenomics
- Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
- (2018) Bianca C. Bernardo et al. Frontiers in Pharmacology
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- The circulating miRNAs as diagnostic and prognostic markers
- (2018) Alessandro Terrinoni et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- MicroRNAs in Autoimmunity and Hematological Malignancies
- (2018) Mirco Marco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
- (2018) Kioomars Saliminejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Autophagy, Cancer Stem Cells & Drug Resistance
- (2018) Alexandra G. Smith et al. JOURNAL OF PATHOLOGY
- MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5
- (2018) Xiaoxiao Jiang et al. LEUKEMIA & LYMPHOMA
- TransmiR v2.0: an updated transcription factor-microRNA regulation database
- (2018) Zhan Tong et al. NUCLEIC ACIDS RESEARCH
- microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle
- (2018) Yan Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal microRNA expression in the course of hematological malignancies
- (2018) Agnieszka Szymczyk et al. Cancer Management and Research
- Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression
- (2017) Huimin Zhou et al. GENE
- Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
- (2017) Seung-Hyun Jung et al. HAEMATOLOGICA
- MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
- (2017) Bo Tang et al. INTERNATIONAL JOURNAL OF CANCER
- The role of exosomes and miRNAs in drug-resistance of cancer cells
- (2017) Duc-Hiep Bach et al. INTERNATIONAL JOURNAL OF CANCER
- LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway
- (2017) Yilan Wu et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor
- (2017) Yan-Ni Liang et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia
- (2017) Suganthi S. Ramachandran et al. LEUKEMIA & LYMPHOMA
- Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
- (2017) Céline Bouvy et al. LEUKEMIA RESEARCH
- Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
- (2017) Cristina Pérez-Ramírez et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
- (2017) Yan Li et al. ONCOLOGY REPORTS
- Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit
- (2017) Tobias Otto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptive mechanisms of resistance to anti-neoplastic agents
- (2017) Bibiana I. Ferreira et al. MedChemComm
- MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
- (2017) Yi Xiao et al. Oncology Letters
- Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
- (2017) Simona Salati et al. Oncotarget
- A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells
- (2017) Anne-Sophie Espadinha et al. Oncotarget
- Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
- (2017) Askar Obulkasim et al. Oncotarget
- Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
- (2017) Seung-Hyun Jung et al. HAEMATOLOGICA
- Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
- (2017) Vanessa Lopes-Rodrigues et al. Scientific Reports
- Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
- (2016) Vanessa Lopes-Rodrigues et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
- (2016) Cristina P.R. Xavier et al. CURRENT CANCER DRUG TARGETS
- High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
- (2016) Sara Correia Marques et al. EXPERIMENTAL HEMATOLOGY
- Extracellular miRNAs as biomarkers in cancer
- (2016) Jennifer F. Barger et al. FOOD AND CHEMICAL TOXICOLOGY
- Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms
- (2016) Hiroto Horiguchi et al. HAEMATOLOGICA
- The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies
- (2016) Xin Li et al. Hematology
- Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines
- (2016) Marwa Hentati-Kallel et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Regulatory mechanisms of microRNA expression
- (2016) Lyudmila F. Gulyaeva et al. Journal of Translational Medicine
- Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
- (2016) Y Qin et al. LEUKEMIA
- MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma
- (2016) Yanjie Li et al. LEUKEMIA RESEARCH
- Special Issue: New Approaches to Counteract Drug Resistance in Cancer
- (2016) M. Vasconcelos MOLECULES
- hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10
- (2016) Hao Xi et al. ONCOLOGY REPORTS
- Role of micro-RNAs in drug resistance of multiple myeloma
- (2016) Jahangir Abdi et al. Oncotarget
- Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
- (2016) Lifen Zhao et al. Oncotarget
- Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
- (2016) Li Zhang et al. Oncotarget
- Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms
- (2016) Hiroto Horiguchi et al. HAEMATOLOGICA
- Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
- (2015) J. Paggetti et al. BLOOD
- Drug resistance-related microRNAs in hematological malignancies: Translating basic evidence into therapeutic strategies
- (2015) Lingling Xie et al. BLOOD REVIEWS
- MicroRNA (miRNA) in cancer
- (2015) Kaladhar B Reddy Cancer Cell International
- Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia
- (2015) X Zhu et al. CANCER GENE THERAPY
- MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein
- (2015) Oshrat Hershkovitz-Rokah et al. CANCER LETTERS
- Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
- (2015) J.-J. Zhao et al. CANCER RESEARCH
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies
- (2015) Agnieszka Dzikiewicz-Krawczyk CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells
- (2015) Feng Lin et al. Journal of Cancer Research and Therapeutics
- Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
- (2015) Fei Li et al. LEUKEMIA RESEARCH
- Limited miR-17-92 overexpression drives hematologic malignancies
- (2015) Laura S. Danielson et al. LEUKEMIA RESEARCH
- miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
- (2015) Sayer Al-harbi et al. Molecular Cancer
- miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
- (2015) Bairong Xia et al. Molecular Cancer
- Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells
- (2015) Xianjuan Shen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles
- (2015) Diana Sousa et al. TRENDS IN MOLECULAR MEDICINE
- Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A
- (2015) Burçin Tezcanlı Kaymaz et al. TUMOR BIOLOGY
- MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
- (2015) Juan Du et al. Oncotarget
- Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
- (2015) Jian Zhang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Regulation of miRNA strand selection: follow the leader?
- (2014) Hedda A. Meijer et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
- (2014) L.-S. Wang et al. BLOOD
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF- B mediates chemoresistance
- (2014) R. Jacamo et al. BLOOD
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type
- (2014) Paloma Silva de Souza et al. CANCER SCIENCE
- Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
- (2014) Yanyan Mei et al. CANCER SCIENCE
- Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells
- (2014) Hugo Seca et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients
- (2014) Dolly Joshi et al. GENE
- miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1
- (2014) FEI LU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-binding site polymorphisms in hematological malignancies
- (2014) Agnieszka Dzikiewicz-Krawczyk Journal of Hematology & Oncology
- MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
- (2014) S Jagannathan et al. LEUKEMIA
- MicroRNA regulons in tumor microenvironment
- (2014) H I Suzuki et al. ONCOGENE
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
- (2013) G. Reid et al. ANNALS OF ONCOLOGY
- Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia Jurkat cells by modulating expression of Fas-associated protein with death domain (FADD)
- (2013) Nami Yamada et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MicroRNAs in hematological malignancies
- (2013) Charles H. Lawrie BLOOD REVIEWS
- The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance
- (2013) O. Lavi et al. CANCER RESEARCH
- Role of microRNA in the pathogenesis of malignant lymphoma
- (2013) Hiroyuki Tagawa et al. CANCER SCIENCE
- Downregulation of miR-217 correlates with resistance of ph+leukemia cells to ABL tyrosine kinase inhibitors
- (2013) Chie Nishioka et al. CANCER SCIENCE
- Mammalian 5′-Capped MicroRNA Precursors that Generate a Single MicroRNA
- (2013) Mingyi Xie et al. CELL
- Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
- (2013) Megan Murray et al. CELL CYCLE
- Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
- (2013) Hugo Seca et al. CURRENT DRUG TARGETS
- MicroRNAs as therapeutic targets in chemoresistance
- (2013) Michela Garofalo et al. DRUG RESISTANCE UPDATES
- Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance
- (2013) Joyce Gong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The network of P-glycoprotein and microRNAs interactions
- (2013) Vanessa Lopes-Rodrigues et al. INTERNATIONAL JOURNAL OF CANCER
- Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
- (2013) Nobuyoshi Kosaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
- (2013) Tint Lwin et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
- (2013) Ye Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
- (2013) MinRan Zhou et al. Journal of Translational Medicine
- MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma
- (2013) Z-X Yan et al. LEUKEMIA
- Loss of p53 and altered miR15-a/16-1→MCL-1 pathway in CLL: insights from TCL1-Tg:p53 −/− mouse model and primary human leukemia cells
- (2013) J Liu et al. LEUKEMIA
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
- (2013) Valentina Manfè et al. PLoS One
- Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
- (2013) Yajuan Li et al. PLoS One
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
- (2013) Neda Mosakhani et al. Molecular Cytogenetics
- miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
- (2012) H. Li et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562
- (2012) Li Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
- (2012) Y. Li et al. BLOOD
- Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
- (2012) Z. Tian et al. BLOOD
- miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
- (2012) Dan-Xia Zhu et al. CARCINOGENESIS
- In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors
- (2012) E. Fonte et al. CLINICAL CANCER RESEARCH
- The dynamics of drug resistance: A mathematical perspective
- (2012) Orit Lavi et al. DRUG RESISTANCE UPDATES
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
- (2012) Haitao Bai et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
- (2012) Y Yu et al. LEUKEMIA
- Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia
- (2012) Masako Harada et al. LEUKEMIA & LYMPHOMA
- Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies
- (2012) Apeng Yang et al. LEUKEMIA & LYMPHOMA
- Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs
- (2012) Xin Huang et al. LEUKEMIA & LYMPHOMA
- Epstein–Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1
- (2012) Joo Hyun Kim et al. LEUKEMIA & LYMPHOMA
- Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
- (2012) Jing-jing Huang et al. MEDICAL ONCOLOGY
- Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits
- (2012) Ritu Jaiswal et al. Molecular Cancer
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Leukemia cell to endothelial cell communication via exosomal miRNAs
- (2012) T Umezu et al. ONCOGENE
- Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
- (2012) Hao Li et al. PHARMACEUTICAL BIOLOGY
- MicroRNA profiling in K-562 cells under imatinib treatment
- (2012) Eleonora Turrini et al. Pharmacogenetics and Genomics
- Cell-to-cell miRNA transfer: From body homeostasis to therapy
- (2012) Roxana S. Redis et al. PHARMACOLOGY & THERAPEUTICS
- miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma
- (2012) Valentina Manfè et al. PLoS One
- Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
- (2012) E Ballabio et al. Blood Cancer Journal
- Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
- (2012) Keitaro Hagiwara et al. Scientific Reports
- Biogenesis of Mammalian MicroRNAs: A Global View
- (2012) Paul Graves et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
- (2011) Inthrani R. Indran et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia
- (2011) A. C. Russ et al. HAEMATOLOGICA
- miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
- (2011) Haitao Bai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
- (2011) Mu Hao et al. Journal of Hematology & Oncology
- An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways
- (2011) M Lv et al. LEUKEMIA
- The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
- (2011) E Rao et al. LEUKEMIA
- Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
- (2011) Mu Hao et al. LEUKEMIA & LYMPHOMA
- Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
- (2011) Xudong Wang et al. LEUKEMIA & LYMPHOMA
- MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?
- (2011) Tereza Lopotová et al. LEUKEMIA RESEARCH
- miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia
- (2011) Vanesa Scholl et al. LEUKEMIA RESEARCH
- miR-153 sensitized the K562 cells to As2O3-induced apoptosis
- (2011) Li Liu et al. MEDICAL ONCOLOGY
- Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
- (2011) Hua Zhang et al. Molecular Cancer
- Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17∼92 Contributes to the Induction of Bim and Initiation of Apoptosis
- (2011) Jason K. Molitoris et al. MOLECULAR ENDOCRINOLOGY
- Novel Regulation of Nuclear Factor-YB by miR-485-3p Affects the Expression of DNA Topoisomerase II and Drug Responsiveness
- (2011) C.-F. Chen et al. MOLECULAR PHARMACOLOGY
- Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
- (2011) E Sotillo et al. ONCOGENE
- Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance
- (2011) Vicky Goler-Baron et al. PLoS One
- A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing
- (2011) J. E. Babiarz et al. RNA
- MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts
- (2011) L S Hodge et al. Blood Cancer Journal
- Single-nucleotide polymorphisms among microRNA: big effects on cancer
- (2011) Feng-Ju Song et al. Chinese Journal of Cancer
- Role for MicroRNAs in Regulating Glucocorticoid Response and Resistance in Multiple Myeloma
- (2011) Michael A. Tessel et al. Hormones & Cancer
- MicroRNA Profiles of Drug-Resistant Myeloma Cell Lines
- (2010) Reinhold Munker et al. ACTA HAEMATOLOGICA
- Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
- (2010) T. Lwin et al. BLOOD
- Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis
- (2010) Yumin Li et al. CANCER SCIENCE
- The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia
- (2010) Erica Salerno et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis
- (2010) Yumin Li et al. Hematology
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Biological functions of microRNAs: a review
- (2010) Yong Huang et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines
- (2010) Jingyi Gu et al. MEDICAL ONCOLOGY
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
- (2010) Etienne Moussay et al. Molecular Cancer
- MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
- (2010) Manuela Ferracin et al. Molecular Cancer
- Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
- (2010) E. I. Zimmerman et al. MOLECULAR PHARMACOLOGY
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
- (2009) A. Kotani et al. BLOOD
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
- (2009) J Rainer et al. LEUKEMIA
- Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
- (2009) T. Kaddar et al. LEUKEMIA RESEARCH
- miR-138 might reverse multidrug resistance of leukemia cells
- (2009) Xiaohong Zhao et al. LEUKEMIA RESEARCH
- MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
- (2009) Edurne San José-Enériz et al. Molecular Cancer
- Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity
- (2009) E. Salerno et al. MOLECULAR CANCER THERAPEUTICS
- Many roads to maturity: microRNA biogenesis pathways and their regulation
- (2009) Julia Winter et al. NATURE CELL BIOLOGY
- Role of microRNAs in hematological malignancies
- (2009) Alessandro Fatica et al. Expert Review of Hematology
- miR-34a as part of the resistance network in chronic lymphocytic leukemia
- (2008) T. Zenz et al. BLOOD
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
- (2008) Dan Jones et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
- (2008) Changchun Xiao et al. NATURE IMMUNOLOGY
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started